One in six children diagnosed with cancer in the United States lives in poverty, and despite uniform treatment in clinical trials, poverty-exposed children are more likely to relapse compared to children who are not exposed to poverty. Dana-Farber Cancer Institute seeks to improve childhood cancer outcomes by investigating poverty as a risk factor for relapse and developing novel poverty-targeted interventions. Listen to a presentation from Dana-Farber’s Kira Bona, MD, MPH, about her lab’s work to identify and alleviate poverty-associated outcome disparities in childhood cancers. The event is hosted by Joanne Wolfe, MD, MPH.
Dana-Farber patient Laura Eastment shares her treatment journey with epidermal growth factor receptor (EGFR) mutant lung cancer. To learn more about the Chen-Huang Center for EGFR-Mutant Lung Cancers at Dana-Farber, please visit: https://www.dana-farber.org/egfr
Annette Stanton, PhD, shared her expertise in managing the emotionaljourney of cancer care at the annual Breast Cancer in Young Adults Virtual Forum Series held in October 2021.To learn more about the Program for Young Adults with Breast Cancer, visit: www.dana-farber.org/Young and Strong. A licensed clinical psychologist and an author of more than 250 publications, Dr. Stanton identifies factors that promote or impede psychological and physical health in adults and couples undergoing chronically stressful experiences, with a focus on cancer.
The School Liaison Program and pediatric neuro-oncologist Dr. Tabitha Cooney hosted this virtual informational seminar on the transition to college. Topics included: finding the right fit, accessing support services on campus, and getting medical care away from home.